Literature DB >> 10362326

Renal cell carcinoma: a paradigm of lanthanic disease.

R J Papac1, W J Poo-Hwu.   

Abstract

Renal cell carcinoma is characterized by varied and sometimes obscure manifestations, which include unusual metastatic sites and paraneoplastic and vascular syndromes. In this review, uncommon metastatic sites and their clinical significance are discussed, particularly the thyroid, nasal structures, vagina, and gastrointestinal sites. Paraneoplastic syndromes appear to be related predominantly to cytokines or immunologic mechanisms. Vascular syndromes are related to the tendency of the tumor to spread by direct venous extension and to complications related to the vascularity of the tumor or its metastases. The recognition of unusual manifestations of renal cell carcinoma is important because these syndromes may lead to the diagnosis. Moreover, paraneoplastic syndromes and vascular findings may not indicate unresectability or incurability.

Entities:  

Mesh:

Year:  1999        PMID: 10362326     DOI: 10.1097/00000421-199906000-00003

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  8 in total

1.  Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.

Authors:  Daniel M Moreira; Boris Gershman; Christine M Lohse; Stephen A Boorjian; John C Cheville; Bradley C Leibovich; Robert Houston Thompson
Journal:  World J Urol       Date:  2016-02-25       Impact factor: 4.226

Review 2.  [Paraneoplastic syndrome in renal cell carcinoma].

Authors:  J Bedke; S Buse; M Kurosch; A Haferkamp; D Jäger; M Hohenfellner
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

3.  Perioperative Considerations in Metastatic Renal Cell Carcinoma.

Authors:  Kate Flavin; Nikhil Vasdev; Jim Ashead; Tim Lane; Damian Hanbury; Paul Nathan; Shanmugasundaram Gowrie-Mohan
Journal:  Rev Urol       Date:  2016

4.  Coexistence of subacute thyroiditis and renal cell carcinoma: a paraneoplastic syndrome.

Authors:  Ekrem Algün; Süleyman Alici; Cevat Topal; Serdar Ugras; Reha Erkoç; M Emin Sakarya; Nese Ozbey
Journal:  CMAJ       Date:  2003-04-15       Impact factor: 8.262

5.  Paraneoplastic hormones: parathyroid hormone-related protein (PTHrP) and erythropoietin (EPO) are related to vascular endothelial growth factor (VEGF) expression in clear cell renal cell carcinoma.

Authors:  Chen-chen Feng; Guan-xiong Ding; Ning-hong Song; Xuan Li; Zhong Wu; Hao-wen Jiang; Qiang Ding
Journal:  Tumour Biol       Date:  2013-06-19

6.  A Rare Subcutaneous Manifestation of Metastatic Renal Cell Carcinoma.

Authors:  Darren Yak Leong Chan; Wei Jin Chua
Journal:  Case Rep Surg       Date:  2016-12-14

7.  Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity.

Authors:  Gang Wang; Da-Ming Zhang; Hai-Ying Zhuang; Chao Yin; Jing Liu; Zi-Chun Wang; Li-Cheng Cai; Ming-Hua Ren; Wan-Hai Xu; Cheng Zhang
Journal:  Chin Med J (Engl)       Date:  2017-09-20       Impact factor: 2.628

8.  Stauffer's syndrome as a prominent manifestation of renal cancer: a case report.

Authors:  Georgios P Kranidiotis; Paraskevi T Voidonikola; Meletios K Dimopoulos; Maria I Anastasiou-Nana
Journal:  Cases J       Date:  2009-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.